President Trump highlighted that, while electronic products were excluded from recent tariff actions, tariffs on semiconductors and pharmaceuticals are expected as part of efforts to address trade imbalances and national security concerns.
The Commerce Department’s Bureau of Industry and Security (BIS) has launched Section 232 investigations into pharmaceuticals and semiconductors, inviting public comments via Federal Register notices scheduled for publication on April 16.
- Section 232 investigation into pharmaceuticals here.
- Section 232 investigation into semiconductors here.
Public comments are due by May 7, 21 days following the Federal Register publication.